ZINC

ZINC was reported 26686 times

ZINC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 54 0.7714
1 RADIATION INFLAMMATION 28 0.3500
2 COPPER DEFICIENCY 22 0.1833
3 SEDATION COMPLICATION 316 0.1237
4 PRODUCT ADMINISTRATION ISSUE 21 0.1005
5 RHINOCEREBRAL MUCORMYCOSIS 30 0.0865
6 MULTIPLE DRUG THERAPY 61 0.0809
7 CREATININE RENAL CLEARANCE DECREASED 323 0.0806
8 CARBUNCLE 21 0.0742
9 APPENDICOLITH 27 0.0698
10 CREATININE RENAL CLEARANCE INCREASED 51 0.0682
11 NECROSIS ISCHAEMIC 21 0.0456
12 PULMONARY PAIN 109 0.0373
13 BLOOD CALCIUM DECREASED 359 0.0319
14 SINUSITIS FUNGAL 25 0.0312
15 GENITAL ULCERATION 22 0.0286
16 FACET JOINT SYNDROME 92 0.0282
17 MONOCLONAL IMMUNOGLOBULIN PRESENT 21 0.0276
18 PERIPHERAL VENOUS DISEASE 110 0.0269
19 ONYCHOMYCOSIS 115 0.0262
20 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 22 0.0237
21 ONYCHOMADESIS 95 0.0226
22 RHEUMATIC FEVER 100 0.0224
23 FINGER DEFORMITY 108 0.0223
24 INFUSION SITE DISCHARGE 39 0.0222
25 ORTHOSTATIC HYPOTENSION 355 0.0204
26 PNEUMONIA STREPTOCOCCAL 22 0.0201
27 FEMALE GENITAL TRACT FISTULA 33 0.0193
28 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 23 0.0183
29 RENAL FUNCTION TEST ABNORMAL 83 0.0179
30 HYPOTHALAMO-PITUITARY DISORDER 26 0.0178
31 SINUS PAIN 41 0.0176
32 MACROCYTOSIS 20 0.0172
33 CONGENITAL ANOMALY 130 0.0168
34 PRODUCT LABEL CONFUSION 97 0.0166
35 GENITAL PAIN 24 0.0162
36 BLEPHAROSPASM 97 0.0154
37 INFUSION SITE BRUISING 33 0.0153
38 BREAST CANCER STAGE III 91 0.0140
39 NAIL DISORDER 119 0.0136
40 MUSCLE INJURY 111 0.0134
41 SEDATION 350 0.0134
42 TOTAL LUNG CAPACITY DECREASED 21 0.0131
43 GENITAL HERPES 20 0.0131
44 C-REACTIVE PROTEIN ABNORMAL 81 0.0126
45 SPUTUM INCREASED 27 0.0125
46 HAEMORRHAGIC DIATHESIS 44 0.0123
47 CALCULUS URINARY 19 0.0123
48 EYELID PAIN 25 0.0123
49 ENDOMETRIAL CANCER 27 0.0123
50 SEASONAL ALLERGY 172 0.0121
51 WOUND INFECTION 130 0.0119
52 WOUND SECRETION 45 0.0115
53 RESPIRATORY SYMPTOM 32 0.0112
54 LIP DRY 102 0.0112
55 CHRONIC SINUSITIS 42 0.0112
56 GRIP STRENGTH DECREASED 98 0.0111
57 PARANASAL SINUS DISCOMFORT 42 0.0111
58 INFUSION SITE PRURITUS 35 0.0111
59 EAR CONGESTION 30 0.0111
60 OBESITY 175 0.0110
61 INFUSION SITE HAEMORRHAGE 36 0.0109
62 HYPERCHOLESTEROLAEMIA 104 0.0108
63 DIASTOLIC DYSFUNCTION 33 0.0107
64 BLADDER SPASM 20 0.0107
65 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 76 0.0106
66 NASAL POLYPS 52 0.0105
67 TASTE DISORDER 213 0.0105
68 BACK INJURY 114 0.0105
69 APLASTIC ANAEMIA 54 0.0103
70 HYPERPHOSPHATAEMIA 22 0.0102
71 DUODENAL ULCER PERFORATION 76 0.0102
72 LIVE BIRTH 83 0.0099
73 ARTHRITIS INFECTIVE 46 0.0099
74 JOINT RANGE OF MOTION DECREASED 133 0.0099
75 COGNITIVE DISORDER 458 0.0098
76 SKIN ATROPHY 56 0.0097
77 BLOOD PHOSPHORUS INCREASED 26 0.0095
78 NEUROLOGICAL DECOMPENSATION 22 0.0095
79 HELICOBACTER INFECTION 97 0.0094
80 WOUND COMPLICATION 32 0.0093
81 BURSITIS 110 0.0091
82 FOLLICULITIS 95 0.0091
83 MULTIPLE ALLERGIES 71 0.0090
84 DEPRESSED LEVEL OF CONSCIOUSNESS 356 0.0090
85 COELIAC DISEASE 88 0.0090
86 INFUSION SITE SWELLING 56 0.0089
87 SKIN LACERATION 95 0.0087
88 APPETITE DISORDER 57 0.0086
89 SKIN WARM 50 0.0086
90 MOBILITY DECREASED 616 0.0086
91 FIBROSIS 26 0.0084
92 FOOD POISONING 43 0.0080
93 LUNG OPACITY 21 0.0080
94 SKIN ODOUR ABNORMAL 31 0.0079
95 ABDOMINAL MASS 21 0.0078
96 INFUSION SITE REACTION 23 0.0077
97 INFUSION SITE PAIN 98 0.0076
98 IRRITABLE BOWEL SYNDROME 163 0.0076
99 BALANCE DISORDER 657 0.0076
100 SUSPECTED COVID-19 25 0.0076
101 ABNORMAL FAECES 62 0.0076
102 OSTEOARTHRITIS 319 0.0075
103 SPINAL STENOSIS 31 0.0075
104 HAND DEFORMITY 98 0.0075
105 AORTIC STENOSIS 26 0.0075
106 AMMONIA INCREASED 38 0.0074
107 PEMPHIGUS 93 0.0074
108 TENDERNESS 77 0.0074
109 BRAIN FOG 115 0.0073
110 VITAMIN B12 DECREASED 21 0.0073
111 BLOOD URIC ACID INCREASED 42 0.0073
112 BLADDER PAIN 23 0.0072
113 SYNOVITIS 130 0.0072
114 EPIGASTRIC DISCOMFORT 28 0.0072
115 WOUND 200 0.0071
116 PROSTATOMEGALY 28 0.0071
117 VULVOVAGINAL DRYNESS 23 0.0071
118 TUMOUR MARKER INCREASED 34 0.0071
119 RALES 41 0.0071
120 INSURANCE ISSUE 107 0.0070
121 EYELID MARGIN CRUSTING 20 0.0069
122 IRON DEFICIENCY 31 0.0069
123 OVERWEIGHT 37 0.0069
124 EAR PAIN 133 0.0068
125 PARANASAL SINUS HYPERSECRETION 26 0.0068
126 INFUSION SITE ERYTHEMA 57 0.0068
127 LOWER RESPIRATORY TRACT INFECTION 307 0.0067
128 FIBROMYALGIA 164 0.0067
129 SKIN PAPILLOMA 27 0.0067
130 BODY HEIGHT DECREASED 72 0.0067
131 VASCULAR DEVICE INFECTION 30 0.0066
132 POLYMYALGIA RHEUMATICA 21 0.0066
133 SINUS DISORDER 129 0.0065
134 SCIATICA 103 0.0065
135 KNEE ARTHROPLASTY 135 0.0064
136 ADVERSE REACTION 85 0.0064
137 BRONCHIECTASIS 43 0.0064
138 NIGHT SWEATS 202 0.0063
139 ANAL INCONTINENCE 56 0.0062
140 GLOSSITIS 22 0.0062
141 MYASTHENIA GRAVIS 50 0.0062
142 DYSPHORIA 31 0.0061
143 LYMPHOEDEMA 42 0.0061
144 PERICARDITIS 102 0.0061
145 UPPER-AIRWAY COUGH SYNDROME 50 0.0061
146 LIVER FUNCTION TEST INCREASED 130 0.0060
147 ARTHROPATHY 336 0.0060
148 PHOTOPHOBIA 113 0.0060
149 ORAL CANDIDIASIS 78 0.0059
150 DYSLIPIDAEMIA 30 0.0059
151 SARS-COV-2 TEST POSITIVE 78 0.0059
152 PRODUCT ADMINISTRATION INTERRUPTED 46 0.0059
153 HYPOPHOSPHATAEMIA 43 0.0058
154 HIDRADENITIS 53 0.0058
155 ROSACEA 27 0.0058
156 HIATUS HERNIA 75 0.0058
157 INTERVERTEBRAL DISC DEGENERATION 53 0.0057
158 SENSITIVE SKIN 42 0.0057
159 GAIT INABILITY 190 0.0057
160 ORAL PAIN 127 0.0057
161 BLOOD IRON DECREASED 67 0.0056
162 INCORRECT DRUG ADMINISTRATION RATE 24 0.0056
163 SINUSITIS 574 0.0056
164 CARBOHYDRATE ANTIGEN 125 INCREASED 19 0.0056
165 PAROSMIA 42 0.0056
166 LIMB INJURY 151 0.0056
167 RENAL CYST 44 0.0055
168 MENISCUS INJURY 34 0.0055
169 COVID-19 970 0.0055
170 NORMAL NEWBORN 30 0.0055
171 NECK PAIN 306 0.0055
172 SPINAL OSTEOARTHRITIS 48 0.0055
173 OESOPHAGEAL DISORDER 21 0.0054
174 FUNGAL SKIN INFECTION 22 0.0054
175 BLOOD MAGNESIUM DECREASED 47 0.0054
176 BLOOD CHOLESTEROL INCREASED 252 0.0054
177 HYPOAESTHESIA ORAL 81 0.0054
178 EXOSTOSIS 49 0.0054
179 DIZZINESS POSTURAL 52 0.0054
180 GLOSSODYNIA 120 0.0054
181 MACULAR DEGENERATION 64 0.0054
182 BLOOD CALCIUM INCREASED 47 0.0054
183 IMPAIRED HEALING 175 0.0053
184 HORDEOLUM 23 0.0053
185 SNEEZING 119 0.0053
186 DERMATITIS CONTACT 60 0.0053
187 LIVER INJURY 129 0.0053
188 CANDIDA INFECTION 88 0.0052
189 HERPES VIRUS INFECTION 30 0.0052
190 MUSCLE STRAIN 45 0.0052
191 TONGUE DISCOMFORT 22 0.0052
192 GASTROINTESTINAL PAIN 57 0.0052
193 COVID-19 PNEUMONIA 61 0.0052
194 TENDON PAIN 39 0.0051
195 CONSTIPATION 1122 0.0051
196 IRON DEFICIENCY ANAEMIA 47 0.0051
197 NEURALGIA 123 0.0051
198 FOOD ALLERGY 39 0.0050
199 FOOT DEFORMITY 56 0.0050
200 HAEMOGLOBIN INCREASED 23 0.0050
201 AUTOIMMUNE THYROIDITIS 19 0.0050
202 EAR DISORDER 23 0.0050
203 ATTENTION DEFICIT HYPERACTIVITY DISORDER 21 0.0050
204 RESPIRATORY TRACT CONGESTION 79 0.0050
205 WEIGHT FLUCTUATION 52 0.0050
206 SWELLING OF EYELID 31 0.0049
207 BLADDER DISORDER 49 0.0049
208 DYSSTASIA 144 0.0049
209 SINUS CONGESTION 66 0.0049
210 SLEEP DISORDER 342 0.0048
211 WHEEZING 287 0.0048
212 FULL BLOOD COUNT DECREASED 97 0.0048
213 PRE-EXISTING CONDITION IMPROVED 30 0.0048
214 PARAESTHESIA ORAL 69 0.0048
215 DRY MOUTH 387 0.0048
216 THINKING ABNORMAL 88 0.0047
217 CARPAL TUNNEL SYNDROME 66 0.0047
218 INFLAMMATION 243 0.0047
219 EXERCISE TOLERANCE DECREASED 27 0.0047
220 JOINT STIFFNESS 123 0.0047
221 PSORIATIC ARTHROPATHY 190 0.0047
222 BLISTER 262 0.0047
223 PSEUDOMONAS INFECTION 40 0.0047
224 HEPATIC ENCEPHALOPATHY 43 0.0046
225 APPENDICITIS 43 0.0046
226 STOMATITIS 278 0.0046
227 DYSPHEMIA 20 0.0046
228 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 219 0.0046
229 MICTURITION URGENCY 52 0.0045
230 WALKING AID USER 30 0.0045
231 POST PROCEDURAL INFECTION 37 0.0045
232 TYPE 2 DIABETES MELLITUS 153 0.0045
233 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 23 0.0045
234 FAECES SOFT 33 0.0045
235 LIGAMENT RUPTURE 20 0.0045
236 GASTROOESOPHAGEAL REFLUX DISEASE 364 0.0045
237 SYMPTOM RECURRENCE 27 0.0045
238 VITAMIN D DEFICIENCY 44 0.0045
239 WRIST FRACTURE 54 0.0045
240 HOT FLUSH 339 0.0045
241 YELLOW SKIN 21 0.0045
242 ABDOMINAL DISTENSION 468 0.0045
243 SECRETION DISCHARGE 56 0.0045
244 MUSCULOSKELETAL STIFFNESS 391 0.0045
245 LIGAMENT SPRAIN 44 0.0044
246 JOINT INJURY 95 0.0044
247 VITAMIN D DECREASED 38 0.0044
248 SPINAL PAIN 52 0.0044
249 FAILURE TO THRIVE 23 0.0044
250 PERIORBITAL SWELLING 25 0.0044
251 OBSTRUCTIVE AIRWAYS DISORDER 49 0.0044
252 BLOOD TESTOSTERONE DECREASED 30 0.0044
253 JAW DISORDER 24 0.0044
254 GASTROENTERITIS VIRAL 79 0.0044
255 POLYARTHRITIS 23 0.0044
256 RHINORRHOEA 282 0.0044
257 BLOOD POTASSIUM DECREASED 131 0.0044
258 FULL BLOOD COUNT ABNORMAL 46 0.0043
259 INCREASED TENDENCY TO BRUISE 40 0.0043
260 GOUT 78 0.0043
261 EYE INFECTION 49 0.0043
262 CARDIAC FLUTTER 28 0.0043
263 SCAR 74 0.0043
264 PRODUCT DISTRIBUTION ISSUE 40 0.0043
265 LUNG DISORDER 210 0.0043
266 EMPHYSEMA 43 0.0043
267 EYE PAIN 240 0.0042
268 HYPERVOLAEMIA 21 0.0042
269 DIABETIC NEUROPATHY 21 0.0042
270 DIVERTICULUM 30 0.0042
271 NOCTURIA 51 0.0042
272 PERIPHERAL SWELLING 647 0.0042
273 SLEEP APNOEA SYNDROME 80 0.0042
274 OCULAR DISCOMFORT 47 0.0042
275 HEAD DISCOMFORT 74 0.0042
276 MIGRAINE 399 0.0042
277 PROCEDURAL COMPLICATION 32 0.0042
278 DECUBITUS ULCER 34 0.0042
279 INFUSION RELATED REACTION 275 0.0041
280 GINGIVAL PAIN 33 0.0041
281 SKIN FISSURES 81 0.0041
282 THIRST 74 0.0041
283 UPPER RESPIRATORY TRACT INFECTION 191 0.0041
284 THERAPEUTIC PRODUCT EFFECT DECREASED 185 0.0041
285 SCAB 47 0.0041
286 PRODUCTIVE COUGH 196 0.0041
287 OROPHARYNGEAL DISCOMFORT 37 0.0041
288 EAR DISCOMFORT 42 0.0041
289 POLLAKIURIA 170 0.0041
290 TROPONIN INCREASED 31 0.0041
291 DECREASED INTEREST 24 0.0041
292 PURPURA 36 0.0041
293 RED BLOOD CELL COUNT DECREASED 116 0.0041
294 MUSCULAR WEAKNESS 460 0.0040
295 POOR QUALITY SLEEP 87 0.0040
296 SINUS HEADACHE 24 0.0040
297 MUSCLE SPASMS 740 0.0040
298 SYSTEMIC LUPUS ERYTHEMATOSUS 143 0.0040
299 BRONCHITIS 298 0.0040
300 FEELING COLD 112 0.0040
301 CONTUSION 387 0.0040
302 HYPERAESTHESIA 33 0.0040
303 NASAL DRYNESS 25 0.0040
304 SKIN DISORDER 133 0.0040
305 EAR INFECTION 106 0.0040
306 ERUCTATION 77 0.0040
307 DYSPNOEA EXERTIONAL 149 0.0040
308 PRODUCT DOSE OMISSION IN ERROR 112 0.0040
309 HEART RATE ABNORMAL 22 0.0039
310 ILLNESS 406 0.0039
311 RETCHING 84 0.0039
312 INCORRECT PRODUCT ADMINISTRATION DURATION 85 0.0039
313 FACIAL PAIN 35 0.0039
314 BOWEL MOVEMENT IRREGULARITY 30 0.0039
315 BLOOD TEST ABNORMAL 55 0.0039
316 ARTHROPOD BITE 29 0.0039
317 BACTERIAL INFECTION 73 0.0039
318 ORAL HERPES 76 0.0039
319 DYSPEPSIA 383 0.0039
320 PHARYNGEAL SWELLING 38 0.0039
321 HIP SURGERY 21 0.0039
322 THROAT IRRITATION 174 0.0039
323 VARICOSE VEIN 20 0.0039
324 PRODUCT USE COMPLAINT 61 0.0039
325 APHTHOUS ULCER 30 0.0039
326 RENAL PAIN 41 0.0039
327 THERAPY CHANGE 38 0.0039
328 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 21 0.0039
329 FLATULENCE 218 0.0038
330 FALL 1278 0.0038
331 TENDONITIS 59 0.0038
332 FUNGAL INFECTION 127 0.0038
333 OXYGEN SATURATION DECREASED 214 0.0038
334 INITIAL INSOMNIA 39 0.0038
335 HEPATIC ENZYME INCREASED 259 0.0038
336 URINARY TRACT INFECTION 648 0.0038
337 NASOPHARYNGITIS 700 0.0038
338 PRODUCT FORMULATION ISSUE 25 0.0038
339 ONYCHOCLASIS 26 0.0038
340 NASAL CONGESTION 222 0.0038
341 IMPAIRED QUALITY OF LIFE 54 0.0038
342 HEPATITIS 96 0.0037
343 MUSCULOSKELETAL CHEST PAIN 58 0.0037
344 MUSCLE SPASTICITY 46 0.0037
345 RESPIRATORY TRACT INFECTION 97 0.0037
346 OROPHARYNGEAL PAIN 344 0.0037
347 PERIPHERAL COLDNESS 51 0.0037
348 SCOLIOSIS 23 0.0037
349 MUSCLE ATROPHY 47 0.0037
350 BRUXISM 20 0.0037
351 PNEUMONIA BACTERIAL 34 0.0037
352 MUSCLE TIGHTNESS 60 0.0037
353 PYELONEPHRITIS 32 0.0037
354 AGEUSIA 92 0.0037
355 ALOPECIA 724 0.0037
356 RESTLESS LEGS SYNDROME 67 0.0037
357 SENSATION OF FOREIGN BODY 31 0.0037
358 DRY EYE 183 0.0037
359 MALNUTRITION 41 0.0037
360 PSYCHIATRIC SYMPTOM 27 0.0037
361 SQUAMOUS CELL CARCINOMA OF SKIN 22 0.0036
362 ASTHENOPIA 20 0.0036
363 COUGH 1020 0.0036
364 SLUGGISHNESS 37 0.0036
365 ABDOMINAL DISCOMFORT 608 0.0036
366 DENTAL CARIES 40 0.0036
367 DECREASED ACTIVITY 39 0.0036
368 URINARY INCONTINENCE 107 0.0036
369 FOREIGN BODY SENSATION IN EYES 23 0.0036
370 MUSCULOSKELETAL DISCOMFORT 62 0.0036
371 FEEDING DISORDER 73 0.0036
372 SALIVARY HYPERSECRETION 36 0.0036
373 EPILEPSY 110 0.0036
374 MEMORY IMPAIRMENT 493 0.0036
375 MIDDLE INSOMNIA 67 0.0036
376 HEART RATE IRREGULAR 81 0.0036
377 SWELLING 335 0.0036
378 BODY TEMPERATURE INCREASED 73 0.0036
379 SKIN HAEMORRHAGE 53 0.0036
380 DISEASE RECURRENCE 170 0.0036
381 MUSCULOSKELETAL DISORDER 68 0.0036
382 MUSCULOSKELETAL PAIN 187 0.0036
383 DEFAECATION URGENCY 25 0.0036
384 BACK DISORDER 58 0.0036
385 TOOTH INFECTION 47 0.0036
386 FREQUENT BOWEL MOVEMENTS 96 0.0036
387 OSTEOPOROSIS 146 0.0035
388 C-REACTIVE PROTEIN INCREASED 129 0.0035
389 HEPATIC STEATOSIS 66 0.0035
390 PARAESTHESIA 557 0.0035
391 JOINT SWELLING 425 0.0035
392 INTENTIONAL DOSE OMISSION 100 0.0035
393 THYROID DISORDER 54 0.0035
394 BLOOD PRESSURE SYSTOLIC INCREASED 68 0.0035
395 VIRAL INFECTION 116 0.0035
396 HYPOAESTHESIA 521 0.0035
397 CORONAVIRUS INFECTION 23 0.0035
398 BLOOD URINE PRESENT 66 0.0035
399 VITREOUS FLOATERS 34 0.0035
400 ULCER 55 0.0035
401 ANOSMIA 50 0.0035
402 PLATELET COUNT INCREASED 45 0.0034
403 INSOMNIA 919 0.0034
404 FATIGUE 2679 0.0034
405 APHONIA 48 0.0034
406 GASTROINTESTINAL DISORDER 308 0.0034
407 NEPHROPATHY 32 0.0034
408 NEUROPATHY PERIPHERAL 326 0.0034
409 PAIN IN JAW 97 0.0034
410 HAEMOGLOBIN ABNORMAL 22 0.0034
411 IMMUNE SYSTEM DISORDER 45 0.0034
412 DRUG-INDUCED LIVER INJURY 107 0.0034
413 URINE ODOUR ABNORMAL 20 0.0034
414 BACK PAIN 790 0.0034
415 ULCER HAEMORRHAGE 23 0.0034
416 TRICUSPID VALVE INCOMPETENCE 27 0.0034
417 ATRIAL FLUTTER 27 0.0034
418 INFUSION SITE EXTRAVASATION 21 0.0034
419 PRODUCT SUPPLY ISSUE 24 0.0034
420 ASTHENIA 1264 0.0034
421 BLOOD PRESSURE INCREASED 513 0.0034
422 IMMUNODEFICIENCY 50 0.0034
423 DRY THROAT 34 0.0033
424 FRUSTRATION TOLERANCE DECREASED 27 0.0033
425 PELVIC FRACTURE 26 0.0033
426 BASAL CELL CARCINOMA 52 0.0033
427 HAIR GROWTH ABNORMAL 23 0.0033
428 FLANK PAIN 31 0.0033
429 CONTRAINDICATED PRODUCT ADMINISTERED 100 0.0033
430 DYSPHONIA 193 0.0033
431 POLYURIA 27 0.0033
432 PRODUCT DOSE OMISSION ISSUE 969 0.0033
433 TEMPERATURE INTOLERANCE 34 0.0033
434 GAIT DISTURBANCE 630 0.0033
435 HICCUPS 27 0.0033
436 BLOOD SODIUM DECREASED 62 0.0033
437 DYSURIA 121 0.0033
438 NASAL DISCOMFORT 26 0.0033
439 ARTHRALGIA 1362 0.0033
440 HYPOTENSION 655 0.0033
441 HYPERLIPIDAEMIA 39 0.0033
442 CHEST DISCOMFORT 334 0.0033
443 BLOOD THYROID STIMULATING HORMONE INCREASED 30 0.0033
444 NERVE COMPRESSION 30 0.0032
445 HYPERSOMNIA 93 0.0032
446 LACRIMATION INCREASED 98 0.0032
447 SENSORY DISTURBANCE 52 0.0032
448 BONE PAIN 189 0.0032
449 INABILITY TO AFFORD MEDICATION 32 0.0032
450 NODULE 42 0.0032
451 DYSGEUSIA 239 0.0032
452 CYSTITIS 102 0.0032
453 TINNITUS 147 0.0032
454 BURNING SENSATION 224 0.0032
455 PAIN 1962 0.0032
456 ROTATOR CUFF SYNDROME 41 0.0032
457 OEDEMA 173 0.0032
458 DRUG INTOLERANCE 308 0.0032
459 INTENTIONAL PRODUCT USE ISSUE 279 0.0032
460 AUTOIMMUNE DISORDER 31 0.0032
461 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 54 0.0032
462 CHILLS 371 0.0032
463 WHITE BLOOD CELL COUNT DECREASED 343 0.0032
464 PRODUCT AVAILABILITY ISSUE 72 0.0032
465 RIB FRACTURE 65 0.0032
466 TRANSFUSION 33 0.0031
467 TOOTH DISORDER 70 0.0031
468 PHARYNGITIS STREPTOCOCCAL 34 0.0031
469 HAIR TEXTURE ABNORMAL 42 0.0031
470 SKIN LESION 86 0.0031
471 WHITE BLOOD CELL COUNT ABNORMAL 20 0.0031
472 CONJUNCTIVITIS 58 0.0031
473 INCONTINENCE 33 0.0031
474 SKIN INFECTION 35 0.0031
475 HYSTERECTOMY 27 0.0031
476 HYPOKINESIA 45 0.0031
477 CELLULITIS 156 0.0031
478 TOOTHACHE 56 0.0031
479 ARTHRITIS 243 0.0031
480 MOVEMENT DISORDER 99 0.0031
481 FEELING HOT 189 0.0031
482 SPLENOMEGALY 36 0.0031
483 POST PROCEDURAL COMPLICATION 59 0.0031
484 PRODUCT ADMINISTRATION ERROR 62 0.0031
485 TENDON DISORDER 20 0.0031
486 GASTROINTESTINAL INFLAMMATION 24 0.0031
487 VENTRICULAR FIBRILLATION 34 0.0031
488 LOCALISED INFECTION 74 0.0031
489 NERVE INJURY 34 0.0031
490 NEPHROLITHIASIS 140 0.0030
491 EPISTAXIS 228 0.0030
492 BODY TEMPERATURE DECREASED 30 0.0030
493 HYPOGAMMAGLOBULINAEMIA 20 0.0030
494 HOSPICE CARE 30 0.0030
495 HEART RATE INCREASED 300 0.0030
496 PAIN IN EXTREMITY 892 0.0030
497 PRODUCT SUBSTITUTION ISSUE 174 0.0030
498 WEIGHT DECREASED 841 0.0030
499 GASTROINTESTINAL INFECTION 27 0.0030
500 ORAL DISORDER 22 0.0030
501 MYALGIA 510 0.0030
502 HERNIA 58 0.0030
503 WEIGHT INCREASED 671 0.0030
504 TOOTH FRACTURE 33 0.0030
505 FLUID RETENTION 152 0.0030
506 QUALITY OF LIFE DECREASED 40 0.0030
507 ILL-DEFINED DISORDER 181 0.0030
508 HEADACHE 1868 0.0030
509 HYPOPHAGIA 76 0.0030
510 CONCUSSION 23 0.0030
511 BEDRIDDEN 39 0.0030
512 DIARRHOEA 1915 0.0030
513 SKIN EXFOLIATION 250 0.0030
514 DERMATITIS 62 0.0030
515 FEELING ABNORMAL 709 0.0030
516 INTERVERTEBRAL DISC PROTRUSION 64 0.0029
517 HAEMATOCRIT DECREASED 58 0.0029
518 BLOOD PRESSURE ABNORMAL 58 0.0029
519 LYMPHADENOPATHY 103 0.0029
520 POOR VENOUS ACCESS 30 0.0029
521 RED BLOOD CELL SEDIMENTATION RATE INCREASED 32 0.0029
522 LOSS OF LIBIDO 26 0.0029
523 EYE DISCHARGE 30 0.0029
524 BLOOD PRESSURE FLUCTUATION 69 0.0029
525 DECREASED APPETITE 666 0.0029
526 OCULAR HYPERAEMIA 136 0.0029
527 URINE OUTPUT DECREASED 25 0.0029
528 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 49 0.0029
529 RHINITIS 23 0.0028
530 ABDOMINAL PAIN UPPER 587 0.0028
531 SPINAL DISORDER 27 0.0028
532 DIVERTICULITIS 79 0.0028
533 SKIN DISCOLOURATION 131 0.0028
534 TOOTH ABSCESS 29 0.0028
535 SCRATCH 30 0.0028
536 HERPES ZOSTER 163 0.0028
537 CHROMATURIA 64 0.0028
538 INFLUENZA 316 0.0028
539 THERAPY INTERRUPTED 202 0.0028
540 FEELING DRUNK 21 0.0028
541 THERAPY CESSATION 145 0.0028
542 FAECES DISCOLOURED 61 0.0028
543 VISION BLURRED 383 0.0028
544 CARDIOGENIC SHOCK 40 0.0028
545 PROCEDURAL PAIN 77 0.0028
546 ECZEMA 145 0.0028
547 DYSPHAGIA 263 0.0028
548 EYE SWELLING 103 0.0028
549 SKIN SWELLING 24 0.0028
550 ARTERIOSCLEROSIS 26 0.0028
551 OSTEOMYELITIS 50 0.0028
552 FISTULA 31 0.0028
553 SPINAL FRACTURE 55 0.0027
554 HYPERTENSION 581 0.0027
555 DIZZINESS 1368 0.0027
556 RESPIRATORY DISORDER 82 0.0027
557 PULMONARY CONGESTION 36 0.0027
558 IMMUNOSUPPRESSION 24 0.0027
559 HEAD INJURY 86 0.0027
560 MUSCLE DISORDER 22 0.0027
561 CONFUSIONAL STATE 435 0.0027
562 END STAGE RENAL DISEASE 49 0.0027
563 CHOLELITHIASIS 88 0.0027
564 BLOOD PRESSURE DECREASED 178 0.0027
565 INCREASED APPETITE 51 0.0027
566 DYSPNOEA 1507 0.0027
567 HEPATIC CIRRHOSIS 50 0.0027
568 CLOSTRIDIUM DIFFICILE INFECTION 58 0.0027
569 DYSARTHRIA 100 0.0027
570 DEMENTIA 74 0.0026
571 BLOOD ALBUMIN DECREASED 21 0.0026
572 RHEUMATOID ARTHRITIS 300 0.0026
573 IMPAIRED DRIVING ABILITY 30 0.0026
574 PALPITATIONS 309 0.0026
575 TRANSIENT ISCHAEMIC ATTACK 89 0.0026
576 SPUTUM DISCOLOURED 25 0.0026
577 PRESYNCOPE 64 0.0026
578 PNEUMONIA 851 0.0026
579 THROAT TIGHTNESS 71 0.0026
580 GROIN PAIN 23 0.0026
581 PANIC ATTACK 95 0.0026
582 PRURITUS 1001 0.0026
583 RASH PRURITIC 141 0.0026
584 SKIN ULCER 67 0.0026
585 CONDITION AGGRAVATED 788 0.0026
586 ORAL DISCOMFORT 36 0.0026
587 ERECTILE DYSFUNCTION 66 0.0026
588 PULMONARY THROMBOSIS 28 0.0026
589 GINGIVAL BLEEDING 35 0.0026
590 UPPER LIMB FRACTURE 51 0.0026
591 PULMONARY FIBROSIS 49 0.0026
592 SCHIZOPHRENIA 31 0.0025
593 LOWER LIMB FRACTURE 49 0.0025
594 KIDNEY INFECTION 50 0.0025
595 DEPRESSION 579 0.0025
596 PHOTOSENSITIVITY REACTION 42 0.0025
597 LABORATORY TEST ABNORMAL 75 0.0025
598 LETHARGY 146 0.0025
599 RASH 1106 0.0025
600 RESPIRATORY SYNCYTIAL VIRUS INFECTION 22 0.0025
601 ANKLE FRACTURE 39 0.0025
602 HIP FRACTURE 81 0.0025
603 FLUSHING 256 0.0025
604 NIGHTMARE 87 0.0025
605 THERAPY NON-RESPONDER 113 0.0025
606 DEHYDRATION 335 0.0025
607 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 131 0.0025
608 VERTIGO 153 0.0025
609 INFLUENZA LIKE ILLNESS 206 0.0025
610 DRUG EFFECT LESS THAN EXPECTED 37 0.0025
611 ACUTE RESPIRATORY FAILURE 48 0.0025
612 EYE DISORDER 82 0.0025
613 LIMB DISCOMFORT 77 0.0025
614 HYPERSENSITIVITY 461 0.0025
615 HAEMOPTYSIS 69 0.0025
616 VAGINAL DISCHARGE 25 0.0025
617 APATHY 36 0.0025
618 HALLUCINATION 186 0.0025
619 EYE IRRITATION 142 0.0025
620 DIPLOPIA 64 0.0025
621 ASTHMA 278 0.0025
622 PRESCRIBED UNDERDOSE 49 0.0025
623 INTENTIONAL PRODUCT MISUSE 215 0.0025
624 NAUSEA 1942 0.0025
625 ASCITES 72 0.0024
626 SQUAMOUS CELL CARCINOMA 23 0.0024
627 DRY SKIN 326 0.0024
628 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 440 0.0024
629 SMALL INTESTINAL OBSTRUCTION 30 0.0024
630 COLITIS 92 0.0024
631 GENERALISED OEDEMA 30 0.0024
632 IMPAIRED GASTRIC EMPTYING 33 0.0024
633 PLATELET COUNT DECREASED 258 0.0024
634 HEART RATE DECREASED 85 0.0024
635 BONE DISORDER 44 0.0024
636 INTESTINAL OBSTRUCTION 91 0.0024
637 HYPOTHYROIDISM 77 0.0024
638 EYE INFLAMMATION 23 0.0024
639 DEVICE RELATED INFECTION 37 0.0024
640 PRODUCT USE IN UNAPPROVED INDICATION 595 0.0024
641 EATING DISORDER 51 0.0024
642 DISTURBANCE IN ATTENTION 129 0.0024
643 APHASIA 72 0.0024
644 CHEST PAIN 440 0.0024
645 RASH MACULAR 83 0.0024
646 OSTEOPENIA 36 0.0024
647 INFECTION 343 0.0024
648 THERAPEUTIC RESPONSE UNEXPECTED 106 0.0024
649 MASS 33 0.0024
650 DISCOMFORT 144 0.0024
651 ATRIAL FIBRILLATION 229 0.0023
652 BREAST PAIN 25 0.0023
653 ABDOMINAL PAIN 543 0.0023
654 THROMBOSIS 187 0.0023
655 RENAL DISORDER 108 0.0023
656 MYOPATHY 20 0.0023
657 DEPRESSED MOOD 122 0.0023
658 CHOKING 45 0.0023
659 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 164 0.0023
660 EMOTIONAL DISORDER 71 0.0023
661 TREMOR 382 0.0023
662 URTICARIA 385 0.0023
663 SOMNOLENCE 462 0.0023
664 COORDINATION ABNORMAL 32 0.0023
665 IMPAIRED WORK ABILITY 49 0.0023
666 THERAPEUTIC RESPONSE SHORTENED 76 0.0023
667 PRODUCT TASTE ABNORMAL 31 0.0023
668 HAEMOGLOBIN DECREASED 235 0.0023
669 CRYING 83 0.0023
670 PULMONARY MASS 34 0.0023
671 ANXIETY 649 0.0023
672 BLOOD POTASSIUM INCREASED 37 0.0023
673 VISUAL IMPAIRMENT 282 0.0023
674 ROAD TRAFFIC ACCIDENT 95 0.0023
675 TENDON RUPTURE 28 0.0023
676 INJURY 159 0.0023
677 ACCIDENT 27 0.0023
678 PULMONARY HYPERTENSION 47 0.0023
679 CYST 28 0.0023
680 OEDEMA PERIPHERAL 274 0.0022
681 HEPATOMEGALY 22 0.0022
682 ELECTROLYTE IMBALANCE 26 0.0022
683 SPEECH DISORDER 117 0.0022
684 LIVER DISORDER 99 0.0022
685 MOUTH ULCERATION 47 0.0022
686 AMNESIA 145 0.0022
687 CATARACT 132 0.0022
688 VENTRICULAR EXTRASYSTOLES 23 0.0022
689 MITRAL VALVE INCOMPETENCE 25 0.0022
690 HAEMORRHOIDS 43 0.0022
691 DERMATITIS ATOPIC 116 0.0022
692 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
693 CHOLECYSTECTOMY 25 0.0022
694 INTERNAL HAEMORRHAGE 25 0.0022
695 HALLUCINATION, VISUAL 46 0.0022
696 PROSTATIC SPECIFIC ANTIGEN INCREASED 30 0.0022
697 PHARYNGITIS 27 0.0022
698 TOXICITY TO VARIOUS AGENTS 366 0.0022
699 MUSCLE TWITCHING 50 0.0022
700 MALAISE 950 0.0022
701 MATERNAL EXPOSURE DURING PREGNANCY 193 0.0022
702 HYPOACUSIS 93 0.0022
703 FEELING JITTERY 41 0.0021
704 COMPLICATION ASSOCIATED WITH DEVICE 31 0.0021
705 SEXUAL DYSFUNCTION 25 0.0021
706 GALLBLADDER DISORDER 38 0.0021
707 VOMITING 997 0.0021
708 MULTIPLE ORGAN DYSFUNCTION SYNDROME 60 0.0021
709 PAIN OF SKIN 57 0.0021
710 CORONARY ARTERY OCCLUSION 29 0.0021
711 IRRITABILITY 127 0.0021
712 WHITE BLOOD CELL COUNT INCREASED 81 0.0021
713 INJECTION SITE REACTION 145 0.0021
714 OESOPHAGITIS 23 0.0021
715 DIABETES MELLITUS 160 0.0021
716 BRAIN INJURY 21 0.0021
717 OFF LABEL USE 1828 0.0021
718 ANAEMIA 396 0.0021
719 LOSS OF CONSCIOUSNESS 266 0.0021
720 ABSCESS 33 0.0021
721 HYPERHIDROSIS 266 0.0021
722 STAPHYLOCOCCAL INFECTION 68 0.0021
723 FOOT FRACTURE 39 0.0021
724 SWOLLEN TONGUE 64 0.0020
725 BLOOD COUNT ABNORMAL 31 0.0020
726 COLD SWEAT 36 0.0020
727 DYSKINESIA 83 0.0020
728 GENERAL PHYSICAL HEALTH DETERIORATION 236 0.0020
729 DECREASED IMMUNE RESPONSIVENESS 20 0.0020
730 SPINAL OPERATION 25 0.0020
731 BACTERAEMIA 24 0.0020
732 CHRONIC KIDNEY DISEASE 153 0.0020
733 PETECHIAE 21 0.0020
734 HUNGER 28 0.0020
735 HAIR COLOUR CHANGES 25 0.0020
736 SEIZURE 231 0.0020
737 DISORIENTATION 79 0.0020
738 CORONARY ARTERY DISEASE 60 0.0020
739 LYMPHOCYTE COUNT DECREASED 35 0.0020
740 MOOD SWINGS 63 0.0020
741 DISABILITY 39 0.0020
742 NERVOUSNESS 103 0.0020
743 INJECTION SITE BRUISING 157 0.0020
744 ERYTHEMA 404 0.0020
745 HIP ARTHROPLASTY 30 0.0020
746 SKIN CANCER 42 0.0019
747 PYREXIA 673 0.0019
748 MENTAL IMPAIRMENT 47 0.0019
749 HAEMATOCHEZIA 107 0.0019
750 GASTRITIS 51 0.0019
751 SEPSIS 216 0.0019
752 SWELLING FACE 126 0.0019
753 EYE PRURITUS 65 0.0019
754 SEROTONIN SYNDROME 37 0.0019
755 BLOOD TRIGLYCERIDES INCREASED 34 0.0019
756 MUSCLE RIGIDITY 23 0.0019
757 GLAUCOMA 37 0.0019
758 BLOOD UREA INCREASED 32 0.0019
759 RECTAL HAEMORRHAGE 82 0.0019
760 MENTAL STATUS CHANGES 53 0.0019
761 HAEMATURIA 65 0.0019
762 ADRENAL INSUFFICIENCY 23 0.0019
763 ANGER 64 0.0019
764 JOINT DISLOCATION 20 0.0019
765 CLOSTRIDIUM DIFFICILE COLITIS 20 0.0019
766 COLITIS ULCERATIVE 84 0.0019
767 DELUSION 29 0.0019
768 MALIGNANT MELANOMA 25 0.0019
769 MULTIPLE SCLEROSIS 89 0.0019
770 THERAPY PARTIAL RESPONDER 29 0.0019
771 URINARY RETENTION 62 0.0019
772 TOOTH EXTRACTION 23 0.0018
773 ECONOMIC PROBLEM 28 0.0018
774 ABNORMAL DREAMS 51 0.0018
775 CHOLECYSTITIS 22 0.0018
776 UVEITIS 25 0.0018
777 MOOD ALTERED 50 0.0018
778 ACTIVITIES OF DAILY LIVING IMPAIRED 36 0.0018
779 PARALYSIS 26 0.0018
780 VASCULITIS 21 0.0018
781 DRUG ABUSE 150 0.0018
782 CARDIOMEGALY 22 0.0018
783 PRODUCT USE ISSUE 334 0.0018
784 PLEURAL EFFUSION 108 0.0018
785 REBOUND EFFECT 20 0.0018
786 PNEUMOTHORAX 28 0.0018
787 WITHDRAWAL SYNDROME 74 0.0018
788 TREATMENT FAILURE 146 0.0018
789 BLOOD CREATININE INCREASED 115 0.0018
790 SUICIDAL IDEATION 160 0.0017
791 SEPTIC SHOCK 76 0.0017
792 ABDOMINAL PAIN LOWER 44 0.0017
793 GASTRIC ULCER 33 0.0017
794 ADVERSE DRUG REACTION 155 0.0017
795 NEOPLASM PROGRESSION 60 0.0017
796 MENTAL DISORDER 75 0.0017
797 EXPOSURE DURING PREGNANCY 107 0.0017
798 UNEVALUABLE EVENT 130 0.0017
799 POST PROCEDURAL HAEMORRHAGE 20 0.0017
800 CYANOSIS 27 0.0017
801 RASH ERYTHEMATOUS 82 0.0017
802 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 94 0.0017
803 SYNCOPE 171 0.0017
804 NERVOUS SYSTEM DISORDER 53 0.0017
805 FOETAL EXPOSURE DURING PREGNANCY 138 0.0017
806 PNEUMONITIS 46 0.0017
807 DEAFNESS 44 0.0017
808 INJECTION SITE DISCOLOURATION 21 0.0017
809 PRODUCT PRESCRIBING ERROR 40 0.0017
810 DRUG INTERACTION 266 0.0017
811 ASPARTATE AMINOTRANSFERASE INCREASED 89 0.0017
812 ANGINA PECTORIS 48 0.0017
813 FEAR 45 0.0017
814 SURGERY 98 0.0017
815 INJECTION SITE SWELLING 128 0.0017
816 CARDIAC DISORDER 156 0.0017
817 UNDERDOSE 121 0.0017
818 LIP SWELLING 55 0.0016
819 PELVIC PAIN 30 0.0016
820 CYTOPENIA 20 0.0016
821 PARANOIA 28 0.0016
822 INJECTION SITE PAIN 498 0.0016
823 NEUTROPHIL COUNT DECREASED 66 0.0016
824 HYPOXIA 57 0.0016
825 LYMPHOMA 25 0.0016
826 RENAL FAILURE 213 0.0016
827 ANHEDONIA 42 0.0016
828 HYPONATRAEMIA 90 0.0016
829 HEMIPARESIS 27 0.0016
830 APPLICATION SITE PAIN 35 0.0016
831 PULMONARY ARTERIAL HYPERTENSION 23 0.0016
832 PSORIASIS 207 0.0016
833 GLYCOSYLATED HAEMOGLOBIN INCREASED 40 0.0016
834 INJECTION SITE PRURITUS 106 0.0016
835 MANIA 26 0.0016
836 EYE HAEMORRHAGE 21 0.0016
837 INTERSTITIAL LUNG DISEASE 76 0.0016
838 PULMONARY OEDEMA 70 0.0016
839 PHARYNGEAL OEDEMA 24 0.0016
840 CARDIAC FAILURE CONGESTIVE 125 0.0016
841 LEUKOCYTOSIS 28 0.0015
842 RASH PAPULAR 34 0.0015
843 MULTIPLE SCLEROSIS RELAPSE 103 0.0015
844 INJECTION SITE ERYTHEMA 186 0.0015
845 TREATMENT NONCOMPLIANCE 82 0.0015
846 PRESCRIBED OVERDOSE 29 0.0015
847 ALANINE AMINOTRANSFERASE INCREASED 92 0.0015
848 HAEMORRHAGE 156 0.0015
849 BLOOD ALKALINE PHOSPHATASE INCREASED 37 0.0015
850 MUCOSAL INFLAMMATION 39 0.0015
851 PLASMA CELL MYELOMA 58 0.0015
852 JAUNDICE 40 0.0015
853 GASTRIC DISORDER 51 0.0015
854 RESPIRATORY DISTRESS 41 0.0015
855 FEMUR FRACTURE 46 0.0015
856 PULMONARY EMBOLISM 141 0.0015
857 BRONCHOSPASM 21 0.0015
858 PALLOR 40 0.0015
859 PRODUCT PRESCRIBING ISSUE 32 0.0015
860 BONE DENSITY DECREASED 46 0.0015
861 EXPOSURE VIA SKIN CONTACT 38 0.0015
862 THERAPEUTIC RESPONSE DECREASED 88 0.0014
863 EXPIRED PRODUCT ADMINISTERED 48 0.0014
864 NEEDLE ISSUE 42 0.0014
865 PRODUCT PHYSICAL ISSUE 29 0.0014
866 INJECTION SITE MASS 53 0.0014
867 TACHYCARDIA 127 0.0014
868 DEVICE USE ISSUE 25 0.0014
869 PANCYTOPENIA 79 0.0014
870 INJECTION SITE HAEMORRHAGE 112 0.0014
871 INJECTION SITE RASH 43 0.0014
872 PRODUCT QUALITY ISSUE 190 0.0014
873 RESTLESSNESS 51 0.0014
874 HAEMATOMA 36 0.0014
875 DEEP VEIN THROMBOSIS 90 0.0014
876 COAGULOPATHY 23 0.0014
877 BLOOD GLUCOSE DECREASED 66 0.0014
878 APPLICATION SITE PRURITUS 31 0.0014
879 AGITATION 100 0.0014
880 VAGINAL HAEMORRHAGE 59 0.0014
881 DEVICE ISSUE 121 0.0013
882 METASTASES TO BONE 22 0.0013
883 LUNG NEOPLASM MALIGNANT 55 0.0013
884 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
885 BRADYCARDIA 69 0.0013
886 INTERNATIONAL NORMALISED RATIO INCREASED 37 0.0013
887 RENAL IMPAIRMENT 109 0.0013
888 DYSTONIA 25 0.0013
889 OVERDOSE 278 0.0013
890 NEOPLASM MALIGNANT 86 0.0013
891 LIVER FUNCTION TEST ABNORMAL 37 0.0013
892 FEBRILE NEUTROPENIA 84 0.0013
893 ABNORMAL BEHAVIOUR 50 0.0013
894 DISEASE PROGRESSION 149 0.0013
895 ACNE 95 0.0013
896 PRURITUS GENERALISED 27 0.0012
897 INCORRECT DOSE ADMINISTERED 282 0.0012
898 HOSPITALISATION 188 0.0012
899 VENTRICULAR TACHYCARDIA 20 0.0012
900 DELIRIUM 42 0.0012
901 EXTRA DOSE ADMINISTERED 49 0.0012
902 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 244 0.0012
903 SKIN BURNING SENSATION 86 0.0012
904 BLOOD GLUCOSE ABNORMAL 22 0.0012
905 BLOOD BILIRUBIN INCREASED 32 0.0012
906 DRUG INEFFECTIVE 1560 0.0012
907 CEREBRAL HAEMORRHAGE 42 0.0012
908 PRODUCT PREPARATION ERROR 24 0.0012
909 PERICARDIAL EFFUSION 27 0.0012
910 UNRESPONSIVE TO STIMULI 30 0.0012
911 AGGRESSION 58 0.0012
912 BLINDNESS 47 0.0012
913 BLOOD GLUCOSE INCREASED 217 0.0012
914 APPLICATION SITE ERYTHEMA 30 0.0011
915 ANAPHYLACTIC REACTION 63 0.0011
916 SHOCK 26 0.0011
917 ACUTE KIDNEY INJURY 173 0.0011
918 HEPATIC FAILURE 34 0.0011
919 PNEUMONIA ASPIRATION 28 0.0011
920 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 26 0.0011
921 TOOTH LOSS 23 0.0011
922 INJECTION SITE URTICARIA 27 0.0011
923 PANCREATITIS 58 0.0011
924 CARDIAC FAILURE 88 0.0011
925 AMENORRHOEA 19 0.0011
926 HYPOKALAEMIA 50 0.0011
927 DEVICE DISLOCATION 47 0.0011
928 PRODUCT COMPLAINT 27 0.0011
929 MALIGNANT NEOPLASM PROGRESSION 109 0.0011
930 CEREBROVASCULAR ACCIDENT 176 0.0010
931 ARRHYTHMIA 49 0.0010
932 HYPERKALAEMIA 36 0.0010
933 SKIN IRRITATION 47 0.0010
934 INJECTION SITE WARMTH 21 0.0010
935 GASTROINTESTINAL HAEMORRHAGE 83 0.0010
936 MEDICATION ERROR 55 0.0010
937 ABASIA 24 0.0010
938 HYPOGLYCAEMIA 47 0.0010
939 RESPIRATORY FAILURE 69 0.0009
940 DRUG ADMINISTRATION ERROR 29 0.0009
941 CARDIAC ARREST 78 0.0009
942 ADVERSE EVENT 87 0.0009
943 ENCEPHALOPATHY 23 0.0009
944 PANCREATITIS ACUTE 21 0.0009
945 DEVICE MALFUNCTION 65 0.0009
946 PSYCHOTIC DISORDER 27 0.0009
947 RHABDOMYOLYSIS 38 0.0009
948 HEPATOTOXICITY 20 0.0009
949 OSTEONECROSIS OF JAW 22 0.0009
950 THROMBOCYTOPENIA 97 0.0009
951 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 40 0.0009
952 INCORRECT DRUG ADMINISTRATION DURATION 24 0.0009
953 OSTEONECROSIS 28 0.0009
954 HYPERGLYCAEMIA 31 0.0008
955 NEUTROPENIA 115 0.0008
956 MYOCARDIAL INFARCTION 145 0.0008
957 HAEMATEMESIS 21 0.0008
958 PRODUCT DOSE OMISSION 54 0.0008
959 DRUG EFFECT INCOMPLETE 30 0.0008
960 RENAL FAILURE ACUTE 35 0.0008
961 METABOLIC ACIDOSIS 26 0.0008
962 VISUAL ACUITY REDUCED 27 0.0008
963 INCORRECT DOSE ADMINISTERED BY DEVICE 21 0.0008
964 PREMATURE BABY 24 0.0008
965 EMOTIONAL DISTRESS 95 0.0008
966 DEVICE LEAKAGE 34 0.0008
967 TARDIVE DYSKINESIA 22 0.0008
968 RESPIRATORY ARREST 21 0.0008
969 DRUG EFFECT DECREASED 41 0.0008
970 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 22 0.0008
971 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 53 0.0007
972 ACCIDENTAL EXPOSURE TO PRODUCT 76 0.0007
973 ACUTE MYOCARDIAL INFARCTION 21 0.0007
974 DEATH 613 0.0007
975 ACCIDENTAL OVERDOSE 26 0.0007
976 LEUKOPENIA 35 0.0007
977 HEPATIC FUNCTION ABNORMAL 25 0.0007
978 DEVICE BREAKAGE 27 0.0007
979 BLOOD CREATINE PHOSPHOKINASE INCREASED 19 0.0007
980 CONVULSION 37 0.0006
981 DRUG DOSE OMISSION 106 0.0006
982 WRONG TECHNIQUE IN DRUG USAGE PROCESS 22 0.0006
983 PRODUCT STORAGE ERROR 53 0.0006
984 BREAST CANCER 55 0.0006
985 CARDIO-RESPIRATORY ARREST 24 0.0006
986 DEVICE DIFFICULT TO USE 35 0.0005
987 DRUG WITHDRAWAL SYNDROME 44 0.0005
988 DRUG DEPENDENCE 76 0.0005
989 SUICIDE ATTEMPT 24 0.0004
990 NO ADVERSE EVENT 71 0.0004
991 DRUG DOSE OMISSION BY DEVICE 24 0.0003
992 PROSTATE CANCER 21 0.0003